Consistent with our observation of its downregulation, promoter hypermethylation and downregulation of GPX3 in melanoma, stomach, head and neck, cervical and lung cancers suggest that GPX3 serves as a tumor suppressor in these cancers50,51. Here, GPX3 is linked to lung carcinoma.